Indication

Acquired blepharoptosis

Acquired blepharoptosis is an abnormal downward displacement or drooping of the upper eyelid margin that develops after birth rather than being present congenitally. Read more about Acquired blepharoptosis

2 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Acquired blepharoptosis therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Acquired blepharoptosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acquired blepharoptosis.

Acquired blepharoptosis is an abnormal downward displacement or drooping of the upper eyelid margin that develops after birth rather than being present congenitally.

Primarily affecting adult and elderly populations, it stems from structural compromise, dehiscence, or stretching of the levator palpebrae superioris aponeurosis (involutional or aponeurotic ptosis), though it can also arise from neurogenic, myogenic, or mechanical dysfunctions.

Clinically, the condition manifests unilaterally or bilaterally with a reduced marginal reflex distance-1 and narrowed palpebral fissure, frequently causing superior visual field deficits, ocular fatigue, and compensatory brow elevation.

Personalize your experience

Follow Acquired blepharoptosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it